January 5, 2009 - Arlington Medical Resources (AMR), a provider of market intelligence for the pharmaceutical and diagnostic imaging industries, reported that the number of micro-bubble echo contrast procedures performed in October 2008 have increased by more than 50 percent, to nearly 18,000 procedures, when compared to May 2008.

Micro-bubble echo contrast procedures began declining sharply in October 2007, from nearly 55,000 procedures in September 2007, as a result of a black box warning issued by the FDA in October 2007.

January 5, 2009 - Frost & Sullivan said it have awarded Toshiba America Medical Systems with its 2008 North American Frost & Sullivan Award for Healthcare Innovation.

NAI Tech Products’ MDR Video RP is designed for analog video recording to disk for fluoroscopy, endoscopy, ultrasound and angiography. It features a an integrated full color label printing in disk drive and can write images and viewer to disk or USB memory. The system comes in a new configuration on a cart with playback monitor and touch-screen user interface.

January 2, 2009 - An Italian study recently found dark chocolate, in moderation, may help prevent cardiovascular disease.

January 2, 2009 - The Society of Chest Pain Centers designated Texas Health Arlington Memorial Hospital yesterday as a Cycle III Chest Pain Center - the highest accreditation possible for treatment of chest pain - making it the first hospital in Texas and one of a handful in the world to receive such a designation.

January 2, 2009 - Itamar Medical, an international medical technology company developing noninvasive diagnostic systems using the peripheral arterial tone (PAT) signal, recently said it received Therapeutic Goods Administration (TGA) clearance for the Endo-PAT2000, certifying its use and distribution in Australia.

January 2, 2009 - Jennifer Mieres, M.D., associate professor of medicine and director of nuclear cardiology (ASNC) at New York University, assumes the presidency of the American Society of Nuclear Cardiology today with a call to physicians, scientists, and technologists to emphasize patient outcomes and restore patient trust in the world of cardiovascular imaging.

December 31, 2008 – According to results from a Phase 2 clinical study (BP-23), Zemiva, when combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved sensitivity for the detection of cardiac ischemia by more than 50 percent (p

December 31, 2008 - The FDA today approved Vasovist Injection (gadofosveset trisodium), manufactured by EPIX Pharmaceuticals, is reportedly the first contrast imaging agent for use in patients undergoing magnetic resonance angiography (MRA).

December 30, 2008 - Sapheneia, a global, ISO-certified imaging services company specializing in diagnostic and analytical image processing solutions, signed an agreement with Karolinska University Hospital in Stockholm, Sweden, allowing Karolinska University Hospital to use and evaluate the Sapheneia Clarity CT Solution to lower radiation dose exposure to patients during diagnostic image studies.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now